Cerca | Webyourself Social Media Platform

ha aggiunto un file Health

2024-11-27 06:00:32 -

Targeting Autoimmune Diseases with OX40 Ligand Inhibitors: Market Size and Projections to 2034

The OX40 ligand inhibitors market is emerging as a critical sector within the field of immuno-oncology, driven by the growing understanding of the role of OX40 (also known as CD134) in the immune system, particularly in modulating immune responses in cancer and autoimmune diseases. OX40 is a costimulatory receptor expressed on activated T cells, and its ligand (OX40L) is found on...

0 Commenti 0 condivisioni 103 Views 0 Anteprima